The National Medical Products Administration approved the market launch of Sodium Acetate Injection.

date
14/07/2026
Recently, the National Medical Products Administration approved Hangzhou Aomei Pharmaceutical Co., Ltd.'s application to market a Class 1 innovative drug, Argatroban Sodium Injection, which is used to antagonize neuromuscular blockade induced by rocuronium bromide. The market approval of this drug provides patients with a new treatment option.
Latest
See all latestmore